This site is intended for healthcare professionals

EU Commission grants conditional approval for Idefirix in highly sensitized kidney transplant patients in the European Union.- Hansa Biopharma

Read time: 1 mins
Last updated:27th Aug 2020
Published:27th Aug 2020
Condition: Transplant Rejection: Kidney
Type: drug
Register free for full access to